西格玛-1受体和Kv1.2之间的动态相互作用塑造了神经元和行为对可卡因的反应
Saïd Kourrich1, Teruo Hayashi, Jian-Ying Chuang
1Cellular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
Cell
|January 22, 2013
概括
暴露于可卡因会增加大脑中的sigma-1受体 (Sig-1R) 活性,增强寻找毒品的行为. 这通过Sig-1R和Kv1.2通道相互作用发生,改变神经元功能和对可卡因的反应.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 西格玛-1受体 (Sig-1R) 是一个参与细胞信号传递的内分泌网膜伴侣.
- 它在寻找毒品,特别是可卡因的行为中的作用是可疑的,但尚未完全理解.
- 具体的大脑区域和细胞机制尚未确定.
研究的目的:
- 为了确定可卡因寻找行为中Sig-1R作用的大脑部位.
- 阐明Sig-1R对神经元对可卡因反应的影响背后的细胞机制.
- 为了研究Sig-1R和离子通道之间的相互作用.
主要方法:
- 活体和体外电生理学.
- 蛋白质与蛋白质相互作用的研究.
- 细胞成像和蛋白质局部化分析.
主要成果:
- 暴露于可卡因会导致D型K ((+) 电流在核 (NAc) 中依赖Sig-1R的增加.
- 这种神经适应导致神经元低活性,并增强对可卡因的行为反应.
- 在Sig-1Rs和Kv1.2通道之间形成一个持久的蛋白质-蛋白质复合体,将它们迁移到血膜中.
结论:
- 动态的Sig-1R-Kv1.2复合体是调节神经元和行为对可卡因反应的关键机制.
- 这种相互作用改变了神经元内在的可塑性.
- 研究结果表明,Sig-1R调制在涉及不适应性可塑性的慢性疾病中具有潜在的治疗意义.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
779
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
779
Excitatory and Inhibitory Effects of Neurotransmitters
12.4K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
720
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
720


